Covered recipient · General Payments record
SALLY KENDALL DUGGAN SFEIR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,282.54
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $387.15 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $174.47 | 6 |
| ABBVIE INC. | $81.50 | 4 |
| GlaxoSmithKline, LLC. | $38.20 | 2 |
| Inspire Medical Systems, Inc. | $24.70 | 1 |
| Medtronic, Inc. | $19.06 | 1 |
| OptiNose US, Inc. | $18.47 | 1 |
| ALK-Abello, Inc | $16.46 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.18 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108176855 | CMS |
| ABBVIE INC. | $17.49 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108176857 | CMS |
| ABBVIE INC. | $21.94 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108176859 | CMS |
| ABBVIE INC. | $14.89 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108176861 | CMS |
| ALK-Abello, Inc | $16.46 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099895173 | CMS |
| GENZYME CORPORATION | $8.14 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139634147 | CMS |
| GENZYME CORPORATION | $31.90 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139634167 | CMS |
| GENZYME CORPORATION | $38.12 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139634177 | CMS |
| GENZYME CORPORATION | $24.95 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139634225 | CMS |
| GENZYME CORPORATION | $28.05 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139634257 | CMS |
| GENZYME CORPORATION | $43.31 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139634281 | CMS |
| GlaxoSmithKline, LLC. | $18.11 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116287320 | CMS |
| GlaxoSmithKline, LLC. | $20.09 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115886456 | CMS |
| Inspire Medical Systems, Inc. | $24.70 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148168394 | CMS |
| Medtronic, Inc. | $19.06 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117013745 | CMS |
| Optinose US, Inc. | $18.47 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142168792 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.29 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151204517 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.